Dzieciatkowska Monika, Hay Ariel, Issaian Aaron, Keele Gregory R, Bevers Shaun, Nemkov Travis, Reisz Julie A, Maslanka Mark, Stephenson Daniel, Moore Amy L, Deng Xutao, Stone Mars, Hansen Kirk C, Kleinman Steve, Norris Philip J, Busch Michael P, Page Grier P, Roubinian Nareg, Xia Yang, Zimring James C, D'Alessandro Angelo
bioRxiv. 2025 May 30:2025.05.27.656446. doi: 10.1101/2025.05.27.656446.
Caffeine is the most widely consumed psychoactive substance globally, yet its peripheral physiological effects remain incompletely understood. Leveraging comprehensive data from 13,091 blood donors in the REDS RBC-Omics study, we identify caffeine as a significant modulator of red blood cell (RBC) storage quality and transfusion outcomes. Elevated caffeine levels were reproducible across multiple donations from 643 recalled donors, selected based on their extremes in hemolytic propensity. Both in the screening and recalled cohorts, higher caffeine levels were associated with disrupted RBC metabolism, characterized by reduced glycolysis, depletion of adenylate pools or 2,3-bisphosphoglycerate, and increased markers of oxidative stress and osmotic fragility, including kynurenine accumulation. These observations were recapitulated in plasma and RBCs of eight volunteers upon consumption of a cup of coffee independently of brewing method (Chemex vs espresso). Clinically, elevated caffeine correlated with increased hemolysis and lower post-transfusion hemoglobin increments, especially pronounced in recipients transfused with RBCs from donors carrying common polymorphisms in the ADORA2b gene, a key regulator of RBC metabolism in hypoxia. These human findings were mechanistically validated using a murine model deficient in ADORA2b, which demonstrated impaired glycolytic flux, compromised antioxidant defenses - including caffeine-dependent direct inhibition of recombinantly-expressed glucose 6-phosphate dehydrogenase, and decreased transfusion efficacy (lower hemoglobin increments, higher bilirubin post-transfusion), effects further exacerbated by caffeine exposure during storage. Our study positions caffeine consumption as a modifiable factor in blood transfusion practice, advocating for precision strategies that integrate genetic and exposome factors, and identifies metabolic interventions to enhance blood quality and clinical outcomes.
Caffeine consumption and genetic variants in the ADORA2b receptor synergistically impair red blood cell metabolism and transfusion efficacy, revealing a modifiable exposome-gene interaction for precision transfusion medicine.
咖啡因是全球消费最广泛的精神活性物质,但其外周生理效应仍未完全了解。利用REDS RBC-组学研究中13091名献血者的综合数据,我们确定咖啡因是红细胞(RBC)储存质量和输血结果的重要调节因子。在643名被召回的献血者的多次献血中,咖啡因水平升高具有可重复性,这些献血者是根据其溶血倾向的极端情况挑选出来的。在筛查队列和被召回队列中,较高的咖啡因水平均与RBC代谢紊乱有关,其特征为糖酵解减少、腺苷酸池或2,3-二磷酸甘油酸耗竭,以及氧化应激和渗透脆性标志物增加,包括犬尿氨酸积累。八名志愿者在饮用一杯咖啡后,无论冲泡方法(Chemex法与意式浓缩法)如何,血浆和RBC中均出现了这些现象。临床上,咖啡因水平升高与溶血增加和输血后血红蛋白增量降低相关,在接受携带ADORA2b基因常见多态性的献血者的RBC输血的受者中尤为明显,ADORA2b基因是缺氧时RBC代谢的关键调节因子。这些人体研究结果在缺乏ADORA2b的小鼠模型中得到了机制验证,该模型显示糖酵解通量受损、抗氧化防御能力受损——包括咖啡因对重组表达的葡萄糖6-磷酸脱氢酶的直接抑制,以及输血效果降低(血红蛋白增量较低、输血后胆红素较高),储存期间接触咖啡因会进一步加剧这些影响。我们的研究将咖啡因摄入定位为输血实践中一个可改变的因素,倡导整合遗传和暴露组因素的精准策略,并确定改善血液质量和临床结果的代谢干预措施。
ADORA2b受体中的咖啡因摄入和基因变异协同损害红细胞代谢和输血效果,揭示了精准输血医学中一种可改变的暴露组-基因相互作用。